Golden
Qiming Venture Partners (USA)

Qiming Venture Partners (USA)

A venture capital and private equity firm investing in early-stage healthcare technology companies in the United States and Europe.

Qiming Venture Partners (USA) is a venture capital and private equity firm investing in early-stage healthcare technology companies in the United States and Europe that is headquartered in Seattle, Washington and was founded in 2017 by Qiming Venture Partners. The firm also has offices in Cambridge, Massachusetts and San Francisco, California. Healthcare technology companies receiving investment from Qiming Venture Partners (USA) are typically operating in the therapeutic, digital health, or medical technology industries. Notable investments made by Qiming Venture Partners (USA) include: WindMIL Therapeutics, ZappRX, Armo Biosciences, Cadent Therapeutics, Cardialen, Kezar Life Sciences, Let's Get Checked, Madaket, My Health Teams, Nuvaira, Platelet Biogenesis, Talaris Therapeutics, and Twine Health. 

Timeline

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References